Odile Boespflug‐Tanguy

10.4k total citations · 1 hit paper
193 papers, 5.8k citations indexed

About

Odile Boespflug‐Tanguy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Odile Boespflug‐Tanguy has authored 193 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 26 papers in Genetics. Recurrent topics in Odile Boespflug‐Tanguy's work include RNA regulation and disease (73 papers), RNA Research and Splicing (42 papers) and Neurogenetic and Muscular Disorders Research (24 papers). Odile Boespflug‐Tanguy is often cited by papers focused on RNA regulation and disease (73 papers), RNA Research and Splicing (42 papers) and Neurogenetic and Muscular Disorders Research (24 papers). Odile Boespflug‐Tanguy collaborates with scholars based in France, United States and Italy. Odile Boespflug‐Tanguy's co-authors include Diana Rodriguez, Anne Fogli, Raphael Schiffmann, Éléonore Eymard-Pierre, Enrico Bertini, Albee Messing, Michael Brenner, B. Dastugue, Toby Johnson and James E. Goldman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Odile Boespflug‐Tanguy

185 papers receiving 5.7k citations

Hit Papers

Mutations in GFAP, encoding glial fibrillary acidic prote... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease
    2001 515 citations Odile Boespflug‐Tanguy, Diana Rodriguez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Odile Boespflug‐Tanguy France 42 3.7k 1.0k 854 839 713 193 5.8k
Stefan Isenmann Germany 38 3.6k 1.0× 1.3k 1.3× 973 1.1× 504 0.6× 316 0.4× 125 6.1k
Andreas F. Mack Germany 44 2.6k 0.7× 945 0.9× 850 1.0× 276 0.3× 530 0.7× 160 5.7k
Peter G. Noakes Australia 39 3.1k 0.8× 1.7k 1.7× 611 0.7× 298 0.4× 925 1.3× 102 5.6k
John Kamholz United States 45 2.8k 0.8× 2.1k 2.1× 774 0.9× 671 0.8× 600 0.8× 138 5.5k
Maria Teresa Bassi Italy 45 3.4k 0.9× 1.1k 1.1× 509 0.6× 793 0.9× 1.1k 1.6× 133 5.7k
Kjeld Møllgård Denmark 45 2.0k 0.5× 1.2k 1.1× 1.2k 1.4× 477 0.6× 379 0.5× 129 5.1k
Nicole I. Wolf Netherlands 41 3.1k 0.8× 594 0.6× 506 0.6× 692 0.8× 301 0.4× 169 4.8k
Albert H. Kim United States 44 2.6k 0.7× 876 0.9× 260 0.3× 380 0.5× 510 0.7× 152 6.3k
Brian Harding United Kingdom 46 2.8k 0.8× 909 0.9× 226 0.3× 1.1k 1.3× 309 0.4× 162 6.9k
Joanne E. Martin United Kingdom 30 1.8k 0.5× 654 0.7× 259 0.3× 1.5k 1.8× 349 0.5× 101 4.7k

Countries citing papers authored by Odile Boespflug‐Tanguy

Since Specialization
Citations

This map shows the geographic impact of Odile Boespflug‐Tanguy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Odile Boespflug‐Tanguy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Odile Boespflug‐Tanguy more than expected).

Fields of papers citing papers by Odile Boespflug‐Tanguy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Odile Boespflug‐Tanguy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Odile Boespflug‐Tanguy. The network helps show where Odile Boespflug‐Tanguy may publish in the future.

Co-authorship network of co-authors of Odile Boespflug‐Tanguy

This figure shows the co-authorship network connecting the top 25 collaborators of Odile Boespflug‐Tanguy. A scholar is included among the top collaborators of Odile Boespflug‐Tanguy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Odile Boespflug‐Tanguy. Odile Boespflug‐Tanguy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bélot, Alexandre, Odile Boespflug‐Tanguy, Guilaine Boursier, et al.. (2025). French protocol for diagnosis and management of type 1 interferonopathies. La Revue de Médecine Interne. 46(6). 320–340.
2.
Cwerman‐Thibault, Hélène, Isabel Torres-Cuevas, Iván Millán, et al.. (2024). Neuroglobin overexpression in cerebellar neurons of Harlequin mice improves mitochondrial homeostasis and reduces ataxic behavior. Molecular Therapy. 32(7). 2150–2175. 1 indexed citations
3.
Darras, Basil T., Giovanni Baranello, Odile Boespflug‐Tanguy, et al.. (2023). FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) (P7-9.009). Neurology. 100(17_supplement_2). 1 indexed citations
4.
Launay, Nathalie, Montserrat Ruíz, Laura Planas‐Serra, et al.. (2023). RINT1 deficiency disrupts lipid metabolism and underlies a complex hereditary spastic paraplegia. Journal of Clinical Investigation. 133(14). 7 indexed citations
5.
Sevin, Caroline, et al.. (2023). Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based study. Orphanet Journal of Rare Diseases. 18(1). 238–238. 2 indexed citations
6.
Oskoui, Maryam, Nicolas Deconinck, Elena Mazzone, et al.. (2023). Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA). Journal of the Neurological Sciences. 455. 121096–121096. 2 indexed citations
7.
Fischer, Clara, Monique Elmaleh, Anita Beggiato, et al.. (2023). Enhancing fetal alcohol spectrum disorders diagnosis with a classifier based on the intracerebellar gradient of volumetric undersizing. Human Brain Mapping. 44(11). 4321–4336. 9 indexed citations
8.
Mattern, Claudia, et al.. (2022). Mutation of Proteolipid Protein 1 Gene: From Severe Hypomyelinating Leukodystrophy to Inherited Spastic Paraplegia. Biomedicines. 10(7). 1709–1709. 13 indexed citations
9.
Dewulf, Joseph P., Elsa Wiame, Imen Dorboz, et al.. (2019). SLC13A3 variants cause acute reversible leukoencephalopathy and α‐ketoglutarate accumulation. Annals of Neurology. 85(3). 385–395. 19 indexed citations
10.
Dorboz, Imen, Hélène Dumay‐Odelot, Yosra Bouyacoub, et al.. (2018). Mutation in POLR3K causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation. Neurology Genetics. 4(6). e289–e289. 55 indexed citations
11.
Schiffmann, Raphael, Anne Fogli, Marjo S. van der Knaap, & Odile Boespflug‐Tanguy. (2012). Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter. Pure Amsterdam UMC. 20 indexed citations
12.
13.
Mochel, Fanny, Catherine Sarret, Éléonore Eymard-Pierre, et al.. (2010). Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(11). 1112–1117. 15 indexed citations
14.
Debost‐Legrand, Anne, Yline Capri, Laëtitia Gouas, et al.. (2010). De novo unbalanced translocation 2;4 characterized by metaphase CGH and array CGH in a child with mental retardation and dysmorphic features. Pathologie Biologie. 59(6). 309–313.
15.
Bauters, Marijke, Hilde Van Esch, Michael J. Friez, et al.. (2008). Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Research. 18(6). 847–858. 92 indexed citations
16.
Mignot, Cyril, Cécile Delarasse, Bruno Della Gaspera, et al.. (2007). Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Experimental Cell Research. 313(13). 2766–2779. 32 indexed citations
17.
Burlina, Alessandro P., Vanni Ferrari, Alberto Burlina, et al.. (2006). N-Acetylaspartylglutamate (NAAG) in Pelizaeusmerzbacher Disease. Advances in experimental medicine and biology. 576. 353–359. 9 indexed citations
18.
Fogli, Anne, Diana Rodriguez, Éléonore Eymard-Pierre, & Odile Boespflug‐Tanguy. (2003). eIF2B et la leucodystrophie des Indiens Cree. médecine/sciences. 19(3). 283–285. 1 indexed citations
19.
20.
Lefai, Étienne, Annie Vincent, Odile Boespflug‐Tanguy, A Tanguy, & Serge Alziari. (1997). Quantitative decrease of human cytochrome c oxidase during development: evidences for a post-transcriptional regulation. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1318(1-2). 191–201. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Isenmann Breakdown of academic impact, for papers by Andreas F. Mack Breakdown of academic impact, for papers by Peter G. Noakes Breakdown of academic impact, for papers by John Kamholz Breakdown of academic impact, for papers by Maria Teresa Bassi Breakdown of academic impact, for papers by Kjeld Møllgård Breakdown of academic impact, for papers by Nicole I. Wolf Breakdown of academic impact, for papers by Albert H. Kim Breakdown of academic impact, for papers by Brian Harding Breakdown of academic impact, for papers by Joanne E. Martin
Rankless by CCL
2026